全文获取类型
收费全文 | 4072400篇 |
免费 | 309315篇 |
国内免费 | 11237篇 |
学科分类
医药卫生 | 4392952篇 |
出版年
2018年 | 44322篇 |
2017年 | 34194篇 |
2016年 | 38692篇 |
2015年 | 43886篇 |
2014年 | 61620篇 |
2013年 | 92947篇 |
2012年 | 123595篇 |
2011年 | 131146篇 |
2010年 | 78820篇 |
2009年 | 75161篇 |
2008年 | 122748篇 |
2007年 | 130264篇 |
2006年 | 132044篇 |
2005年 | 127583篇 |
2004年 | 122792篇 |
2003年 | 118377篇 |
2002年 | 115155篇 |
2001年 | 187417篇 |
2000年 | 192805篇 |
1999年 | 163518篇 |
1998年 | 48641篇 |
1997年 | 43439篇 |
1996年 | 43014篇 |
1995年 | 41706篇 |
1994年 | 38743篇 |
1993年 | 36227篇 |
1992年 | 129852篇 |
1991年 | 125590篇 |
1990年 | 121383篇 |
1989年 | 117199篇 |
1988年 | 108294篇 |
1987年 | 106710篇 |
1986年 | 100777篇 |
1985年 | 96551篇 |
1984年 | 72552篇 |
1983年 | 61870篇 |
1982年 | 37219篇 |
1981年 | 33466篇 |
1979年 | 66650篇 |
1978年 | 47125篇 |
1977年 | 39870篇 |
1976年 | 37372篇 |
1975年 | 39497篇 |
1974年 | 47924篇 |
1973年 | 45772篇 |
1972年 | 43087篇 |
1971年 | 39915篇 |
1970年 | 37265篇 |
1969年 | 35237篇 |
1968年 | 32435篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
991.
992.
ABSTRACT Tryptophan (Trp) is not only a nutrient enhancer but also has systemic effects. Trp metabolites signaling through the well-known aryl hydrocarbon receptor (AhR) constitute the interface of microbiome-gut-brain axis. However, the pathway through which Trp metabolites affect central nervous system (CNS) function have not been fully elucidated. AhR participates in a broad variety of physiological and pathological processes that also highly relevant to intestinal homeostasis and CNS diseases. Via the AhR-dependent mechanism, Trp metabolites connect bidirectional signaling between the gut microbiome and the brain, mediated via immune, metabolic, and neural (vagal) signaling mechanisms, with downstream effects on behavior and CNS function. These findings shed light on the complex Trp regulation of microbiome-gut-brain axis and add another facet to our understanding that dietary Trp is expected to be a promising noninvasive approach for alleviating systemic diseases. 相似文献
993.
Leah H. Cobb Emily M. McCabe Lauren B. Priddy 《Journal of orthopaedic research》2020,38(10):2091-2103
Osteomyelitis, or the infection of the bone, presents a major complication in orthopedics and may lead to prolonged hospital visits, implant failure, and in more extreme cases, amputation of affected limbs. Typical treatment for this disease involves surgical debridement followed by long-term, systemic antibiotic administration, which contributes to the development of antibiotic-resistant bacteria and has limited ability to eradicate challenging biofilm-forming pathogens including Staphylococcus aureus—the most common cause of osteomyelitis. Local delivery of high doses of antibiotics via traditional bone cement can reduce systemic side effects of an antibiotic. Nonetheless, growing concerns over burst release (then subtherapeutic dose) of antibiotics, along with microbial colonization of the nondegradable cement biomaterial, further exacerbate antibiotic resistance and highlight the need to engineer alternative antimicrobial therapeutics and local delivery vehicles with increased efficacy against, in particular, biofilm-forming, antibiotic-resistant bacteria. Furthermore, limited guidance exists regarding both standardized formulation protocols and validated assays to predict efficacy of a therapeutic against multiple strains of bacteria. Ideally, antimicrobial strategies would be highly specific while exhibiting a broad spectrum of bactericidal activity. With a focus on S. aureus infection, this review addresses the efficacy of novel therapeutics and local delivery vehicles, as alternatives to the traditional antibiotic regimens. The aim of this review is to discuss these components with regards to long bone osteomyelitis and to encourage positive directions for future research efforts. 相似文献
994.
995.
996.
997.
Which infants with eczema are at risk of food allergy? Results from a population‐based cohort 下载免费PDF全文
998.
999.
Retreatment in patients with psoriasis achieving response with etanercept after relapse due to treatment interruption: results from the CRYSTEL study 下载免费PDF全文
1000.
H N David M Dhilly M Degoulet G Poisnel C Meckler N Vallée J-é Blatteau J-J Risso M Lemaire D Debruyne J H Abraini 《Translational psychiatry》2015,5(7):e594
We investigated the effects of the noble gas argon on the expression of locomotor sensitization to amphetamine and amphetamine-induced changes in dopamine release and mu-opioid neurotransmission in the nucleus accumbens. We found (1) argon blocked the increase in carrier-mediated dopamine release induced by amphetamine in brain slices, but, in contrast, potentiated the decrease in KCl-evoked dopamine release induced by amphetamine, thereby suggesting that argon inhibited the vesicular monoamine transporter-2; (2) argon blocked the expression of locomotor and mu-opioid neurotransmission sensitization induced by repeated amphetamine administration in a short-term model of sensitization in rats; (3) argon decreased the maximal number of binding sites and increased the dissociation constant of mu-receptors in membrane preparations, thereby indicating that argon is a mu-receptor antagonist; (4) argon blocked the expression of locomotor sensitization and context-dependent locomotor activity induced by repeated administration of amphetamine in a long-term model of sensitization. Taken together, these data indicate that argon could be of potential interest for treating drug addiction and dependence. 相似文献